Prenatal Cannabinoid Exposure: Emerging Evidence of Physiological and Neuropsychiatric Abnormalities
Abstract Clinical reports of cannabis use prevalence during pregnancy vary widely from 3% to upwards of 35% in North America;…
Abstract Clinical reports of cannabis use prevalence during pregnancy vary widely from 3% to upwards of 35% in North America;…
Abstract Background: Neonatal Abstinence Syndrome (NAS) leads to increased length of stay (LOS), which leads to increased healthcare costs, and…
Abstract Background & Aims: Low-phospholipid-associated cholelithiasis (LPAC) syndrome, a rare genetic form of intrahepatic cholelithiasis in adults, is still poorly…
Abstract Nowadays, cannabis is the most consumed illicit drug. The global prevalence of the use of cannabis in 2017 was…
Abstract Objective: To compare the characteristics of mothers of children with Fetal Alcohol Spectrum Disorder (FASD) with mothers of typically…
Abstract Background: The United Nations’ Sustainable Development Goals (SDGs) include reducing the global maternal mortality rate to less than 70…
Abstract Introduction: This study analyze factors associated to cannabis use in pregnant women, its perceived availability, its risk perception and…
Abstract About 80% of the consumers worldwide use herbal medicine (HMs) or other natural products. The percentage may vary significantly…
Abstract Objective To evaluate the demographic characteristics, hospitalization outcomes [severity, length of stay (LOS), and total expense], and comorbidities in…
Abstract Ampullary adenocarcinoma is a rare entity during pregnancy. Diagnosing ampullary adenocarcinoma in pregnancy can be quite challenging, as the…